DeuteRx Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2M

DeuteRx General Information

Description

Operator of a biopharmaceutical drug discovery platform intended to improve medicines for patients. The company's platform offers deuterium-enabled chiral switching and development of deuterium-modified chemical entities with composition of matter patent protection, enabling pharmaceutical researchers and drug developers to develop medicines with modified pharmacological properties.

Contact Information

Website
www.deuterx.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 15 Constitution Drive
  • Suite 1
  • Bedford, NH 03110
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 15 Constitution Drive
  • Suite 1
  • Bedford, NH 03110
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DeuteRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 27-Dec-2012 $2M Completed Startup
1. Seed Round 30-Sep-2015 Completed Startup
To view DeuteRx’s complete valuation and funding history, request access »

DeuteRx Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

DeuteRx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2012135299-A1 2',6'-dioxo-3'-deutero-piperdin-3-yl-isoindoline compounds Inactive 28-Mar-2011
AU-2011329619-A1 3-deutero-pomalidomide Inactive 18-Nov-2010
EP-2640189-A1 3-deutero-pomalidomide Inactive 18-Nov-2010
EP-2640189-A4 3-deutero-pomalidomide Inactive 18-Nov-2010
US-20120302605-A1 3-deutero-pomalidomide Inactive 18-Nov-2010 C07D401/04
To view DeuteRx’s complete patent history, request access »

DeuteRx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

DeuteRx FAQs

  • When was DeuteRx founded?

    DeuteRx was founded in 2012.

  • Where is DeuteRx headquartered?

    DeuteRx is headquartered in Bedford, NH.

  • What is the size of DeuteRx?

    DeuteRx has 5 total employees.

  • What industry is DeuteRx in?

    DeuteRx’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is DeuteRx a private or public company?

    DeuteRx is a Private company.

  • What is DeuteRx’s current revenue?

    The current revenue for DeuteRx is .

  • How much funding has DeuteRx raised over time?

    DeuteRx has raised $4.8M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process